Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $580.0000 (4.5%) ($550.0000 - $580.0000) on Thu. Jan. 21, 2010. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.86% (three month average) | RSI | 47 | Latest Price | $580.0000(4.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.7% a day on average for past five trading days. | Weekly Trend | CAPR declines -2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(4%) IWM(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -2.43% in a week (0% probabilities). IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) VWO(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.43% (StdDev 4.86%) | Hourly BBV | 0 () | Intraday Trend | 1.7% | | | |
|
Resistance Level | $595.13 | 5 Day Moving Average | $580.01(-0%) | 10 Day Moving Average | $569.39(1.86%) | 20 Day Moving Average | $595.13(-2.54%) | To recent high | -27.5% | To recent low | 7.4% | Market Cap | $11.425b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |